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Iron Accumulation in Deep Cortical Layers Accounts for
MRI Signal Abnormalities in ALS: Correlating 7 Tesla MRI
and Pathology
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Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by cortical and spinal motor
neuron dysfunction. Routine magnetic resonance imaging (MRI) studies have previously shown hypointense signal in the
motor cortex on T2-weighted images in some ALS patients, however, the cause of this finding is unknown. To investigate
the utility of this MR signal change as a marker of cortical motor neuron degeneration, signal abnormalities on 3T and 7T MR
images of the brain were compared, and pathology was obtained in two ALS patients to determine the origin of the motor
cortex hypointensity. Nineteen patients with clinically probable or definite ALS by El Escorial criteria and 19 healthy controls
underwent 3T MRI. A 7T MRI scan was carried out on five ALS patients who had motor cortex hypointensity on the 3T FLAIR
sequence and on three healthy controls. Postmortem 7T MRI of the brain was performed in one ALS patient and histological
studies of the brains and spinal cords were obtained post-mortem in two patients. The motor cortex hypointensity on 3T
FLAIR images was present in greater frequency in ALS patients. Increased hypointensity correlated with greater severity of
upper motor neuron impairment. Analysis of 7T T2*-weighted gradient echo imaging localized the signal alteration to the
deeper layers of the motor cortex in both ALS patients. Pathological studies showed increased iron accumulation in
microglial cells in areas corresponding to the location of the signal changes on the 3T and 7T MRI of the motor cortex. These
findings indicate that the motor cortex hypointensity on 3T MRI FLAIR images in ALS is due to increased iron accumulation
by microglia.
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these measures facilitate an improved understanding of the
underlying pathophysiology, they are neither sensitive nor specific
for ALS. Furthermore, there is no definite correlation between
these imaging and electrophysiological parameters and clinical
manifestations of UMN impairment.
Conventional magnetic resonance imaging (MRI) is routinely
performed during the evaluation of patients suspected of having
ALS to exclude other diagnoses that may mimic this condition.
Several MRI signal alterations in the precentral gyrus have been
noted in ALS patients, including hyperintense signal in the
subcortical white matter and hypointense signal in the grey matter
on T2-weighted and fluid attenuated inversion recovery (FLAIR)
MR images [5]. Motor cortex hypointensity correlated with the
severity of clinical UMN dysfunction in one study, and was
proposed as a marker of motor neuron degeneration [6].

Introduction
A reliable objective marker of corticospinal upper motor neuron
(UMN) dysfunction remains elusive despite its importance for
diagnosis and monitoring of disease progression in amyotrophic
lateral sclerosis (ALS). Clinical signs of UMN impairment such as
pathological reflexes and increased tone on neurological examination remain the mainstay for detecting cortical neuronal loss
and corticospinal tract degeneration in motor neuron disease [1].
Reduction in the neuronal marker N-acetyl-aspartate (NAA) on
proton magnetic resonance spectroscopy, decreased fractional
anisotropy on diffusion tensor imaging studies, and prolongation of
central motor conduction time on transcranial magnetic stimulation studies have been suggested as potential markers of
corticospinal motor neuron dysfunction in ALS [2–4]. While
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images, and to determine whether hypointensity in the motor
cortex on the T2-weighted FLAIR MR images can be used as a
marker for degeneration of upper motor neurons.

However, hypointensity on T2-weighted MRI of the motor cortex
is inconsistently present in ALS patients, and its specificity for
neuronal degeneration in ALS is uncertain [7,8]. T2 shortening on
MRI of the motor cortex has been seen in a few other chronic
conditions, mainly in patients over 70 years old [9]. The
underlying cause of the T2 signal reduction (i.e. reduction of the
T2 relaxation time constant) in the motor cortex of ALS patients is
not entirely clear. Iron deposition resulting from the neurodegenerative process was proposed as the cause of signal shortening [10],
but an imaging sequence sensitive for detecting signal alterations
caused by the local susceptibility effects of iron failed to support
this hypothesis [11].
Several neurodegenerative disorders such as neurodegeneration
with brain-iron accumulation and Parkinson disease are known to
have excessive iron accumulation that correspond to signal
alterations on the MR images in various brain regions [12]. In
these diseases, excessive iron accumulation is hypothesized to
cause neuronal damage. In ALS, abnormal iron homeostasis
inducing excessive oxidative stress in the motor neurons has been
postulated to contribute to disease pathogenesis [13], based on
several lines of evidence. For example, axotomy led to elevated
expression of transferrin 1 receptor, resulting in increased iron
uptake into the motor neuron [14]. Quantitative evaluation of iron
demonstrated elevated iron levels particularly in the nucleus of
motor neurons from the cervical spinal cord of ALS patients,
leading to the speculation that increased intraneuronal iron may
confer susceptibility to degeneration in ALS [15]. In addition,
elevated transcripts of ferritin heavy and light subunits were
observed in the spinal cord of the superoxide dismutase 1 (SOD1)
G93A mouse model of familial ALS [16]. The observation that
iron accumulates in SOD1 G37R mouse spinal neurons and glia,
and that there is a delay in the progression of disease with iron
chelator treatment in SOD1 G93A mice further suggested a
pathogenic role of iron in familial ALS [17,18]. A number of
recent studies have investigated the association of polymorphisms
in the HFE gene with ALS. Alteration in the coding region of both
alleles of the HFE gene causes the autosomal recessive iron
overload syndrome hereditary hemochromatosis [19]. Increased
frequency of the H63D variant of HFE has been associated with
neurodegenerative disorders, including ALS, further suggesting a
role of abnormal iron metabolism in ALS [20–23]. The association
between the HFE genotype and ALS, however, has not been
observed in all populations in genome wide association studies
[24,25]. Whether iron misregulation or accumulation in motor
neurons has a causative role in ALS has not been established. As
an early step to investigate the role of iron in ALS, neuroimaging
methods can be used to confirm and localize iron deposition in the
cortex of ALS patients.
Iron deposition in tissue causes a concentration-dependent
irregularity in the local magnetic field and signal loss during MRI
acquisition because iron deposits become magnetized and cause
the surrounding water molecules to both accumulate phase and
lose phase coherence [26,27]. This property of iron has led to the
use of T2-star (T2*) weighted gradient-echo sequences to detect the
presence of iron in different tissues with greater sensitivity [26,28].
Hemosiderin, deoxyhemoglobin, ferritin, calcium, and air can all
cause phase shifts and signal intensity loss on T2* weighted
gradient-echo images because of local alterations in the magnetic
susceptibility [29]. In MRI with a higher field strength, the
enhanced T2* contrast further increases the sensitivity for detecting
increased iron, as well as provides higher spatial resolution [30].
The purpose of this study was twofold: to better understand the
anatomical basis of the MR signal changes in the motor cortex in
ALS patients through correlation of pathology to high-field MR
PLoS ONE | www.plosone.org

Methods
Ethics Statement
This protocol was approved by the NIH Combined Neuroscience Institutional Review Board. All subjects gave written,
informed consent for the protocol.

Subjects
Nineteen patients with probable or definite ALS by El Escorial
criteria [31], and 19 age-matched healthy controls participated in
the protocol. The ALS patients were prospectively recruited over a
two-year period from two regional academic ALS centers. The
patients also participated in diffusion tensor imaging studies that
were previously reported [4]. All subjects underwent 3T MRI of
the brain. A subset of five ALS patients and three controls also had
7T MRI studies.

Clinical evaluation
A detailed history and neurological examination was obtained
by a neurologist in all subjects. All patients underwent diagnostic
testing to exclude other diseases that may mimic motor neuron
disease and to confirm that they fulfilled the El Escorial diagnostic
criteria for clinically probable or definite ALS. Disease severity was
graded using the revised ALS functional rating scale (ALSFRS-R)
in all subjects. The severity of upper motor neuron dysfunction
was quantified using the upper motor neuron impairment score
(UMN-IS) which was calculated from clinical scales for grading
reflexes [32] and muscle tone [33], and from timed measurements
of fingertapping, gait, and speech, allowing for side- or limbspecific measures. A composite score from 0–5 was generated for
each limb and the cranial region, with normal function = 0, and
higher scores indicating greater UMN impairment [4]. All healthy
controls had a normal neurological examination and ALSFRS-R.

3T Neuroimaging Acquisition
In all subjects, MRI of the brain was performed on a 3.0 tesla
(T) scanner (Philips Achieva, Best, the Netherlands) using a
receive-only, 8-channel head coil. 2D FLAIR imaging data was
obtained. Parameters for the FLAIR imaging sequence were: 57
axial slices, 2.5 mm slice thickness interleaved with no gap and 1
excitation, TE = 140 ms, TR = 11000 ms, TI = 2750 ms, echo
train length 20, 3206219 acquisition matrix and 220 mm field of
view.

7T Neuroimaging Acquisition (In Vivo)
Five ALS patients who did not have significant respiratory or
bulbar impairment that precluded participation in additional MRI
studies and whose 3T scans showed hypointensity on the FLAIR
imaging in the hand knob region of the motor cortex, and 3
healthy controls underwent additional MRI at 7.0 T (Signa
scanner, GE Healthcare) equipped with a Nova Medical transmit
coil and 32-channel receive array. The following contrast
parameters were used: dual gradient echo acquisition with
TE = 14 and 28.5 ms, bandwidth = 62.5 kHz, TR = 1 s, flip angle
60 degrees. The geometric parameters were: 20 slices at 1 mm
slice thickness with 0.5 mm gap, about 15 degrees oblique with
respect to axial, 7686576 matrix with SENSE rate 2 acquisition,
and nominal resolution of 3126312 mm2.

2

April 2012 | Volume 7 | Issue 4 | e35241

Iron Accumulation in ALS Motor Cortex

tissue, as were immunohistochemical stains for ubiquitin, glial
fibrillary acidic protein (GFAP), TDP-43 antibody, phosphorylated TDP-43, and FUS, using methods previously described [35].
Immunocytochemistry for TDP-43 was also carried out on the
control subject’s cortex. The sections were deparaffinized and
rehydrated by passing the slides in serial solutions: 36 for
10 minutes each in xylene, 36 for 5 minutes each in 100%
ethanol, 36 for 3 minutes each in 95% ethanol, once for
5 minutes each in 75% ethanol, 50% ethanol, deionized water,
and phosphate-buffered saline (PBS). The antigens in the sections
were retrieved using a decloaking chamber using a retrieval
solution (10 mM citrate acid, pH 6.0) at 125uC for 20 minutes.
The sections were cooled to room temperature for 30 minutes and
rinsed with deionized water for 5 minutes. The endogenous
peroxidase activities were blocked with 2% hydrogen peroxide.
Non-specific background was blocked with 1% bovine serum
albumin in PBS for 20 minutes at room temperature. Primary
antibodies included those to FUS (11570-1-AP, 1:50 dilution,
Proteintech Group, Chicago, IL), TDP43 (10782-2-AP, 1:4,000
dilution, Protein Tech Group, Chicago, IL), phosphorylated
TDP43 (TIP-PTD-P01, 1:5,000 dilution, Cosmo Bio Co, Tokyo,
Japan) and ubiquitin (PRB-268C, 1:4,000 dilution, Covance,
Emeryville, CA). Primary antibodies were applied to the slides and
incubated at room temperature for 1 hour. After rinsing the slides
36 for 5 minutes each, a biotinylated goat anti-rabbit or antimouse immunoglobulin G (IgG) was applied to the slides as the
secondary antibody (GR608H or GM601H, Biocare Medical,
Concord, CA). The slides were incubated at room temperature for
30 minutes. The excess secondary antibody was removed by
rinsing the slides 36, 5 minutes for each time. The signals were
detected with peroxidase-conjugated streptavidin (BioGenex, San
Ramon, CA) using 3-amino-9-ethylcarbazole as a chromogen.
The slides were counterstained with hematoxylin and sealed with
Aqua Poly/Mount (Polyscience, Warrington, PA). Perls’ DAB
staining for iron, and immunostaining for ferritin and CD68, a
marker for macrophage/microglial cells, were performed on
sections of the motor cortex, premotor cortex, medial orbitofrontal
cortex, and lumbar spinal cord using previously described methods
with some modifications [36]. Briefly, sections were treated with
xylene to remove paraffin and rehydrated. After PBS washes,
sections were incubated in 2% potassium ferrocyanide solution
with 2% hydrochloric acid at room temperature for 1 hour. After
washing, sections were incubated in unactivated DAB solution
with 0.01% nickel chloride followed by the same solution with
0.03% H2O2 for 20 minutes each. For double immunofluorescent
staining, deparaffinized sections were blocked with 4% normal
goat serum, 2% ovalbumin and unlabeled goat anti-mouse IgG
(50 ug/ml, Jackson Laboratories). Rabbit anti-ferritin (1:1,000
dilution, kind gift of Dr. Esther Meyron-Holtz, Technion, Haifa,
Israel) and mouse anti-CD68 (1:500 dilution, Serotec) were
applied to the slides and incubated overnight. On the next day,
the sections were washed and the signals were visualized by
incubating with Alexa Fluor 488/546 conjugated secondary
antibodies for one hour. Slides were mounted with anti-fading
media containing DAPI (Vectashield mounting media, Vector
Lab) to visualize the nucleus. Perls’ DAB staining and immunocytochemistry for CD68 and ferritin were also carried out on the
motor cortex from the control, Parkinson disease, and Alzheimer
disease.

7T Neuroimaging Acquisition (Ex Vivo)
In one ALS patient for whom 3T and 7T MRI were obtained
one year prior to death, one half of the postmortem brain was
sliced in the axial plane for imaging on the 7.0 T Signa scanner
using a Nova Medical volume transmit coil and with a 24-element
receive-only detector array custom built for tissue scanning.
Contrast parameters were: four gradient echo acquisitions with
TE = 23, 30, 37, and 44 ms, bandwidth = 250 kHz, TR = 1 s, flip
angle 55 degrees. Geometric parameters were: 3D acquisition,
102465126160
matrix,
and
nominal
resolution
of
17561756175 mm3.

Neuroimaging Analysis
Each 3T FLAIR sequence was visually assessed by two
independent investigators blinded to the subject’s diagnosis. In
each hemisphere, the motor cortex area corresponding to the
hand knob [34], was identified. The magnitude of hypointensity
on the FLAIR images within the hand knob was compared to the
adjacent postcentral cortex in several axial slices. Signal hypointensity was graded as 0 (absent), 1 (present, mild), or 2 (present,
marked). A preliminary study evaluating the inter-observer
agreement of motor cortex hypointensity showed an agreement
of 7665%.
Gradient echo magnitude images, frequency and R2* maps on
7T were visually inspected for signal alteration in the motor cortex
and other cortical and subcortical regions. For 7T images,
investigators were not blinded to the subject’s diagnosis. Decreased
signal on the magnitude scans and increased signal on R2* maps
were graded as 0 (absent), 1 (present, mild), or 2 (present, marked).
Signal changes on the magnitude scans and R2* maps in the
precentral gyrus were evaluated and compared to other cortical
(cingulate gyrus) and subcortical areas (basal ganglia). In all 7T
imaging studies, the R2* maps were calculated by taking the
inverse logarithm of the ratio of the first and second echo. The
result was divided by the echo time difference to obtain a persecond (Hz) scale. R2* was only calculated in areas with sufficient
signal.

Postmortem examination
The brains and spinal cords of two ALS patients, ages 42 and
51, were removed postmortem in their entirety and were fixed in
formalin. In both patients, the motor cortex hypointensity had
been scored as grade 2 on 3T images, and the R2* signal was
marked on 7T images. Representative sections of the spinal cord,
motor cortex, and other cortical regions from one hemisphere
were processed for standard clinical pathology in six micron thick
paraffin embedded sections. The other hemisphere was used for
additional histochemical and immunocytochemistry studies and
post-mortem imaging studies. Following post-mortem imaging,
tissue blocks were obtained from the regions identified as the preand post-central gyrus in the hand knob region, premotor cortex,
medial orbitofrontal cortex and the occipital cortex. As control for
the histological stains, a block of motor cortex from an age,
gender, and ethnicity-matched control with no known neurological disease was obtained from the New York Brain Bank—The
Taub Institute, Columbia University. Two blocks of motor cortex
from an 85-year-old patient diagnosed with idiopathic Parkinson
disease and a 77-year-old patient with Alzheimer disease were
obtained from the NIH Laboratory of Pathology as neurological
disease controls.
Sections from the ALS patients and the control cortex were
stained with hematoxylin and eosin, Bielchowsky’s silver stain, and
luxol fast blue/cresyl violet. Histochemical stains for aluminum,
calcium, and copper were carried out on one of the ALS patient’s
PLoS ONE | www.plosone.org

Statistical Analysis
All data are presented as mean 6 standard deviation. In all tests
used to analyze clinical parameters and cortical hypointensity, the
statistical significance threshold was set at p,0.05 corrected,
3
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unless otherwise specified. Statistical analysis was performed using
SPSS Statistics version 17.0 and SAS Enterprise Guide version
4.3.

Results
Demographics
Seven ALS patients fulfilled the revised El Escorial criteria for
clinical definite ALS and 12 patients had clinical probable ALS.
The average ALSFRS-R scores was 31 (S.D. = 6) in clinical
definite ALS patients and 38 (S.D. = 6) in clinical probable ALS
patients. Age and gender did not differ between ALS patients and
controls. The ALSFRS-R was lower and UMN-IS was higher in
the patient group compared with the controls (Table 1).

3T Neuroimaging Analysis
On the 3T axial FLAIR MRI sections in ALS patients, a
curvilinear band of decreased signal was identified along the
anterior banks of the central sulcus in the precentral gyrus of both
hemispheres following the gyral pattern and extending into the
parasagittal region. The signal was deep within the cortical grey,
with a patchy appearance (Fig. 1A, arrows). Similar patterns were
not consistently seen in FLAIR images of controls (Fig. 1D,
arrows). Compared to healthy controls, more ALS patients had
higher grades of hypointensity on FLAIR images in the hand knob
of the motor cortex (Fig. 2A). In the 38 ALS hemispheres, the
hand knob hypointensity was graded as marked (grade 2) in 13,
mild (grade 1) in 22, and absent (grade 0) in 3. In contrast, hand
knob hypointensity on FLAIR images in healthy control
hemispheres were grade 0 in 17, grade 1 in 18, and grade 2 in
only 3. ALS was associated with higher hypointensity grades on
the FLAIR images (Fisher’s exact test, p,0.0001), and the
incidence of ALS increased with increasing hand knob hypointensity (Cochran Armitage trend test, p,0.0001). Increasing hand
knob hypointensity grade significantly correlated with greater
motor impairment as determined by the limb specific UMN-IS
(r = 0.56, p,0.01; Fig. 2B) and the ALSFRS-R (r = 20.41). The
hand knob hypointensity score did not correlate with disease
duration.

Figure 1. 3T and 7T MRI in ALS and healthy control. 3T and 7T
brain MRI signal changes in the motor cortex hand knob differed
between ALS patients (A, B, C) and healthy controls (D, E, F). Cortical
hypointensity (arrows) is shown to be present in an ALS patient (Patient
2, age 51) and not in a healthy control on 3T FLAIR (A, D) and 7T
gradient echo magnitude images (B, E). These areas corresponded to
hyperintensity in the 7T R2* maps (C, F). Scale bar represents R2* value in
Hz.
doi:10.1371/journal.pone.0035241.g001

motor cortex in four ALS patients (Fig. 1C) and mild hyperintense
signal in one ALS patient. The hyperintensity extended into the
parasagittal area. The hyperintense signal was discontinuous, with
a patchy appearance. Two of the controls had a grade 1
hypointensity score on the 3T MRI. Similarly, there was mild
decreased signal in the hand knob region on the 7T gradient echo
magnitude images (Fig. 1E). Two control subjects also had mildly
increased signal (Fig. 1F) and one control had markedly increased
signal in the motor cortex on the R2* map. The increased signal on
the R2* map in control subjects was located in a similar
distribution as that seen in ALS patients. In the 7T gradient echo
magnitude scans, a region of decreased signal extended the entire
length of the cortex in the precentral gyrus including the
parasagittal area in ALS patients (Fig. 1B), primarily in the deeper
portions of the cortex. In some images, the hypointensity appeared
to occupy the full thickness of the cortex. Decreased signal in the
gradient echo scans was not seen in the cingulate cortex of ALS
patients or controls, but was present in the basal ganglia of patients
and controls.

7T Neuroimaging Analysis (In Vivo)
Five ALS patients whose 3T FLAIR images had mild or marked
hypointensity in the hand knob of the motor cortex and three
controls underwent scanning on a 7T MRI. Of the 10 ALS
hemispheres, 8 had grade 2 hand knob hypointensity and 2 had
grade 1 hand knob hypointensity. On the 7T scan, the R2* maps
showed marked signal hyperintensity in the deeper portion of the

7T Neuroimaging Analysis (Ex Vivo)
Table 1. Clinical Features of ALS Patients and Healthy
Controls.

ALS

HC

Postmortem 7T imaging of the brain was obtained in one ALS
patient. The R2* map (Fig. 3A) showed hyperintense signal in the
deep layers of the grey matter of the motor cortex. The signal was
patchy in some areas and was separated from white matter by a
band with normal signal intensity. The gradient echo magnitude
scan showed decreased signal in the same layers of the motor
cortex (Fig. 3B). There was a broad band of altered signal at the
gray white junction that was also present in many cortical regions
beyond the motor cortex. No other cortical areas had observable
signal alterations on the gradient echo magnitude scan or R2* map
within the cortical gray matter.

ALS 7T

N

19

19

5

Gender (Male:Female)

9:10

11:8

4:1

58.765.9

Age, years

53.169.4

Disease duration (range),
years

2.361.4 (0.5–5.0)

ALSFRS-R

35.766.8*

48.0

38.067.0*

UMN-IS

1.9660.80*

0.0560.07

1.7660.82*

49.868.6
1.861.2

Clinico-pathological Studies
The gross pathological examination of both brains did not
reveal perceptible global or frontal lobe atrophy. Histological

*ALS significantly different from healthy controls (HC).
doi:10.1371/journal.pone.0035241.t001

PLoS ONE | www.plosone.org

4

April 2012 | Volume 7 | Issue 4 | e35241

Iron Accumulation in ALS Motor Cortex

Figure 3. Ex vivo 7T MRI and corresponding pathology in ALS.
7T MRI signal change corresponded to iron accumulation in deeper
layers of the cortical gray in the hand knob in an ALS patient. Each
panel shows an axial slice of the precentral gyrus, with the cortical gray
matter boundaries indicated by arrows, and the central sulcus and
postcentral gyrus below. (A) R2* map showed patchy hyperintensity in
the precentral gray. Scale bar represents R2* value in Hz. (B) Gradient
echo magnitude image showed hypointensity in the corresponding
region. Pixels correlate to acquisition voxels. (C) Low power micrographs show iron accumulation in the middle and deep layers of the
motor cortex with Perls’ DAB stain. (D) The luxol fast blue stain showed
myelin pallor in the subcortical white matter of the precentral gyrus
compared to the postcentral gyrus. Scale bar, 1 mm.
doi:10.1371/journal.pone.0035241.g003

Figure 2. Frequency of hypointensity grade in the hand knob
of the motor cortex. (A) Higher grades of hypointensity in the hand
knob region on 3T FLAIR MRI occurred with greater frequency in ALS
patients (black bars) than in healthy controls (gray bars). (B) Higher
grades of hypointensity on 3T FLAIR MRI was associated with higher
upper motor neuron impairment score (UMN-IS). Each dot represents
the grade for one hemisphere and the UMN-IS score for the
contralateral limb. Line indicates mean for group. Hypointensity was
rated grade 0 (absent), grade 1 (present, mild), and grade 2 (present,
marked). The UMN-IS is graded from 0–5 with normal function = 0, and
higher scores indicating greater UMN impairment.
doi:10.1371/journal.pone.0035241.g002

the motor cortex of both ALS patients (Fig. 3C, Fig. 5A). The
intracellular iron was observed in small elongated cells with
irregular short processes suggestive of microglia (Fig. 5D, E). The
staining was primarily located in the middle and deep layers of the
motor cortex, sparing the superficial layers. In adjacent counterstained sections, these regions corresponded to a broad layer of
medium-large pyramidal neurons, which was separated from a
deeper cortical layer that contained a few large pyramidal neurons
amid bundles of myelinated fibers (Fig. 3D).
Ferritin immunostaining showed a similar distribution to the
Perls’ DAB staining, suggesting that most of the iron was
sequestered in intracellular ferritin. Immunostaining showed
increased CD68 positive cells in the deep layers of the motor
cortex. Double immunofluorescence studies showed co-localization of ferritin with CD68, indicating that the ferritin was
sequestered in activated microglia (Fig. 6A–D). No ferritin staining
was identified in large nucleated cells in the motor cortex that were
presumed to be healthy neurons. Some Perls’ DAB staining was
also noted in the white matter adjacent to the motor cortex. The
sensory cortex had very slight Perls’ DAB staining (Fig. 3C). There
was no appreciable Perls’ staining in the other cortical areas
examined.

examination of sections from the spinal cord showed typical
pathology for ALS, including loss of motor neurons, reactive
astrocytosis, atrophy of the anterior nerve roots, and axonal
spheroids. Ubiquitin positive neuronal cytoplasmic skein-like
inclusions (Fig. 4A) and Bunina bodies were present in some of
the remaining neurons. In sections from the motor cortex, there
were decreased numbers of large pyramidal cells in the middle and
deep layers of the cortical mantle and pallor of the subcortical
white matter compared to the adjacent postcentral gyrus (Fig. 3D).
Immunostaining for GFAP showed reactive astrocytes. Immunostaining for TDP-43 showed focally increased cytoplasmic
inclusions in some neurons and glial cells (Fig. 4B). Some neurons
and glia lacked nuclear staining for TDP-43. Hyperphosphorylated TDP-43 was only found in the inclusions (Fig. 4C). No
apparent FUS-immunoreactive inclusions were observed. Histochemical stains for aluminum, calcium, and copper showed no
abnormal reactions.

Iron Histology
Perls’ DAB staining revealed abundant cells containing
intracellular iron and occasional extracellular iron deposits in
PLoS ONE | www.plosone.org
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ferritin in the same distribution as the Perls’ DAB staining. The
ferritin immunostaining, which is more specific for intracellular
iron, was less abundant than the Perls’ DAB staining in the section
from the Parkinson patient’s brain. In the tissue from the patient
with Alzheimer disease, there was slight iron staining mainly in the
white matter adjacent to the cortex and a few scattered cells in the
cortex (Fig. 5B). The motor cortex from the control brain had no
staining with Perls’ DAB staining or ferritin immunoreactivity.
In the spinal cord, many cells with increased CD68 immunoreactivity were found in the dorsolateral funiculus (Fig. 7B) and
rarely in the ventral horn. Ferritin co-localized with CD68 staining
(Fig. 7A–D). Large motor neurons appeared to be devoid of iron as
judged by the Perls’ DAB stain (Fig. 4D) and ferritin immunoreactivity. Activated microglial cells containing iron were mostly
present in the dorsolateral white matter.

Discussion
We suggest that the T2 shortening observed in the motor cortex
on MR images of the brain in ALS patients is caused by iron
accumulation within microglia. The ferritin-laden microglial cells
are primarily found in the middle and deep layers of the motor
cortex among the few surviving large pyramidal neurons, amidst
reactive astrocytes and cellular debris. This localization coincides
with the locations of the cell bodies of corticospinal and callosal
neurons [37,38]. The signal hypointensity was observed on routine
clinical T2-weighted MRI sequences on a 3T scanner, although it
was better localized in the motor cortex on a 7T MRI scanner
with T2* weighted MRI. The superior spatial resolution and
greater sensitivity to paramagnetic metals of 7T MRI was more
apparent in the ex vivo images which demonstrated signal changes
in the deeper layers of the grey matter that corresponded to the
localization of increased iron on the tissue histology. Although the
MRI signal change was not specific to ALS patients, it occurred
disproportionately in ALS patients compared to age-matched
controls, in agreement with a previous report [39], and the degree
of the signal hypointensity on the 3T FLAIR MRI correlated with
the severity of motor impairment as quantified by the UMN-IS
and ALSFRS-R.
Iron has a critical role as a cofactor in many regulatory enzymes
involved in cellular metabolic pathways, such as the electron

Figure 4. Immunohistochemistry of cellular inclusions and iron
histology in an ALS patient. (A) Ubiquitin reactive neuronal
cytoplasmic inclusion with a filamentous appearance (arrow) in motor
cortical neuron. (B, C) The neuronal cytoplasmic inclusions (arrows)
were reactive with TDP-43 (B) and phosphorylated TDP-43 (C). Glial cell
inclusions (B, white arrow heads) were also TDP-43 positive. (D) Spinal
motor neurons (arrow heads) did not show iron accumulation with
Perls’ DAB stain which was present in erythrocytes in the same section
(arrows). Scale bar, 100 mm (A–C); 20 mm (D).
doi:10.1371/journal.pone.0035241.g004

To evaluate the specificity of the Perls’ DAB iron stains in the
motor cortex, we examined tissue from a Parkinson and an
Alzheimer patient. Perls’ DAB staining showed some iron
accumulation in the motor cortex of these patient controls, but
the iron staining was more diffuse in the cortical grey than in the
ALS brains, and also extended into the white matter adjacent to
the cortex (Figure 5B, C). Immunofluorescence studies showed

Figure 5. Histological staining for iron with Perl’s DAB stain in the motor cortex. The panels show comparable planes of section through
the precentral gyrus of brains from the second ALS patient (A), and from the Alzheimer (B) and Parkinson (C) patients. The arrowheads indicate the
pial surface. The arrows indicate the gray-white junction. (A) Low power magnification showing iron accumulation in the middle and deeper layers of
cortical gray matter, and at the gray-white junction in a 51-year-old ALS patient. At higher power (D, E) the staining is present in cells with irregular
processes suggestive of microglia in the ALS motor cortex. The lower portion of panel A shows the post-central gyrus with relatively little iron
staining. The iron staining was more diffuse within the motor cortex of Alzheimer (B) and Parkinson (C) patients and was also present in the
subcortical white matter. Scale bars, 1 mm (A–C), 10 mm (D, E).
doi:10.1371/journal.pone.0035241.g005
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Figure 6. Double immunofluorescent labeling of ferritin-rich microglia in the motor cortex of an ALS patient. Immunostaining for
ferritin in green (A) and CD68, a marker of microglia, in red (B) labeling showed co-localization in yellow (D, merge) indicating increased microglial
ferritin in the motor cortex of an ALS patient. (C) DAPI immunofluorescence, in blue, shows nuclear labeling. Scale bar, 20 mm.
doi:10.1371/journal.pone.0035241.g006

iron as they scavenge debris that remains after neuronal
degeneration. Previous evidence is mixed on the question of
whether iron misregulation contributes to ALS pathogenesis. In
the CNS, the iron transport protein transferrin is a component of
Bunina bodies [48], an intracytoplasmic inclusion in spinal motor
neurons that is considered to be a pathological hallmark of ALS.
The observation of elevated levels of serum ferritin in ALS patients
is thought to indicate a general perturbation of iron metabolism
[49,50]. However, neither serum nor CSF iron levels were found
to be consistently elevated [49,51], suggesting increased ferritin
may be a non-specific acute phase reactant in response to
inflammatory conditions [52]. While cortical motor neurons are
not known to have increased iron levels in ALS, misregulation of
iron regulatory proteins leading to accumulation in spinal motor
neurons and glia was seen in the G37R SOD1 mutant mice [17].
Neurodegeneration and iron accumulation in oligodendroglia
were also seen in mutant mice with targeted deletions of iron
regulatory protein-2 [40,53]. We could not identify iron
accumulation within cortical or spinal motor neurons in our
patient, which may indicate that if iron misregulation is the
primary pathology, its origin is in non-neuronal cells. Of note,
there was also no evidence of systemic iron overload in our ALS
patients.
Activated microglial cells are a prominent component in both
acute CNS injuries and chronic neurodegenerative disorders,
including ALS [54]. An important function of the microglia is
phagocytosis of cellular debris after neuronal injury, and this has
been suggested to provide a more favorable environment to
facilitate the repair process [55]. Consistent with their role in
removal of degenerated tissue, many microglial cells were seen in
the motor cortex and spinal cord where degenerating motor
neurons and their axons are found. Iron and microglia are known
to accumulate at the sites of neurodegeneration in Alzheimer and
Parkinson disease [56]. Microglial iron accumulation has been
reported in the striatum of the transgenic mouse model of
Huntington disease [57] and in the leukocortical lesions of
multiple sclerosis patients [58]. The iron laden microglial cells in
our ALS patients were mainly found in the deeper layers of the
motor cortex. The association between regions with degenerating

transport chain in the mitochondria. It is particularly important in
the central nervous system (CNS) due to the high metabolic
activity of the brain. Although brain iron content increases with
age [12], pathological accumulation of iron is postulated to be
pathogenic in several neurodegenerative disorders such as
Parkinson disease, neurodegeneration with brain iron accumulation, and Alzheimer disease [40]. Increased iron concentration has
also been reported in the ventral spinal cord of ALS patients by
laser microprobe mass spectroscopy [15]. Our study showed that
iron was also increased in the motor cortex in two ALS patients
using histological methods. Even though the motor cortex is
known to have the highest concentration of iron in the human
cerebral cortex, it is usually undetectable on histologic sections
from normal individuals who are less than 65 years old [41], as we
also found in our control brain. In our study, iron accumulation in
the motor cortex was abundant despite the young age of the two
ALS patients who were 42 and 51 years old, and the iron was
mainly found in microglia. This localization in the cortical grey
differed from previous histologic studies of brain iron in individuals
without neurological disorders in which intracellular iron accumulation in the cortex was mostly found in oligodendroglia
[42,43]. Increased iron staining has been reported in the
microglia, but mainly in older individuals [12]. We also observed
iron accumulation in the motor cortex of a Parkinson disease
patient, although the distribution of iron was more diffuse
compared to the ALS patients. Although quantitative brain MRI
and pathology studies measuring iron content in Parkinson disease
patients have shown increased microglial iron in the substantia
nigra [44–46], iron staining in the motor cortex has received little
attention. In the Parkinson control tissue, accumulation of iron in
the motor cortex may be related to the rostral progression of
neurodegeneration as disease progresses [47]. Additionally, the
patient controls were over age 75 and may also have had agerelated accumulation of iron [12]. Similar to previous studies of
changes in iron content with age, increased iron was not observed
in other cortical areas of the brain [41].
It is uncertain what leads to the increased iron deposition in the
motor cortex: misregulation of iron metabolism in motor neurons
or microglia could cause disease, or microglia could accumulate

Figure 7. Double immunofluorescent labeling of ferritin-rich microglia in the dorsolateral white matter from the spinal cord of an
ALS patient. Immunostaining for ferritin in green (A) and CD68, a marker of microglia, in red (B) labeling showed co-localization (arrows) in yellow
(D, merge) indicating increased microglial ferritin in the corticospinal tract from the spinal cord of an ALS patient. (C) DAPI immunofluorescence, in
blue, shows nuclear labeling. Scale bar, 30 mm.
doi:10.1371/journal.pone.0035241.g007
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neurons and microglial iron accumulation may be related to
microglia’s role in the maintenance of brain iron homeostasis by
scavenging excess iron and storing it in ferritin [59]. Others have
postulated that enhanced microglial iron accumulation results in
pathological function of these cells in disorders such as multiple
sclerosis [60]. We favor the interpretation that the intracellular
iron in the microglial cells is derived from phagocytosis of
degenerated neurons and glial cells. It is uncertain however
whether the initiating event includes a perturbation in the
intracellular iron status of these cells prior to their demise.
The correlation between clinical ratings of motor impairment
and the grade of hypointensity in the motor cortex suggests a
relationship between iron accumulation and progressive neuronal
degeneration. In our ALS patient cohort, the motor cortex
hypointensity in the 3T FLAIR MRI images was more frequently
graded as mild than marked. This may reflect a selection bias for
ALS patients earlier in the course of disease who were able to
tolerate the scanning procedures. Motor cortex hypointensity in
the FLAIR sequence on 3T MR images was present in some
healthy controls with normal neurological examinations, although
it was mostly graded as mild and rarely graded as marked. Some
degree of motor cortex hypointensity is an age related phenomenon and unrelated to neurological disease [8,9]. Interestingly,
iron accumulation in the basal ganglia of rhesus monkeys has been
shown to correlate with declining motor abilities independent of
age [61]. It could be that the focal excessive iron accumulation in
the motor cortex represents a marker of underlying genetic
susceptibility for disturbed brain iron regulatory pathways which
can lead to cortical motor neuron dysfunction. Compared to other
cortical regions, the motor cortex may be particularly vulnerable
to changes in iron homeostasis due to its relative high metabolic
activity [62] and higher concentration of iron. Additional studies
will be necessary to substantiate this hypothesis.
Several different mechanisms have been proposed as the cause
of neurodegeneration in ALS including oxidative stress, glutamate
induced excitotoxicity, and mitochondrial dysfunction [63]. Iron
has been implicated in the pathogenesis of several neurodegener-

ative disorders due to its ability to generate cytotoxic reactive
radicals that produce oxidative stress [64]. However, a pathogenic
role in ALS is unclear. Whether intracellular iron accumulation
represents an upstream or downstream phenomenon in the disease
process remains undetermined. Further understanding of normal
iron metabolism in neurons and glial cells is necessary to
determine if aberrant iron regulation contributes to pathology in
ALS. The hypointensity in FLAIR images, albeit not specific for
ALS, may be able to serve as an imaging marker of corticospinal
motor neuron degeneration in individual patients over time or
predict disease progression, as has been suggested in multiple
sclerosis [60]. A limitation of this study was the availability of
motor cortex pathology in only two of the ALS patients who were
imaged. Longitudinal studies of a larger cohort of ALS patients
and controls are needed to determine whether the grading of
hypointensity on T2-weighted MRI increases as degeneration
progresses and whether it represents progressive iron accumulation.
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